RESUMEN
The Brazilian Stroke Society constituted a committee composed by specialists from different areas of Brazil that emitted a viewpoint called "National Opinion", written similar to the consensus pattern. The study purpose is to guide and offer subsidies for diagnosis and therapeutical plans for different situations in cerebrovascular diseases. The current article analyses "neuroprotective agents in stroke", discussing the level of evidence for the use of potential neuroprotective drugs and ongoing clinical trials.
Asunto(s)
Fármacos Neuroprotectores/uso terapéutico , Accidente Cerebrovascular/tratamiento farmacológico , Brasil , Ensayos Clínicos Fase III como Asunto/normas , Humanos , Sociedades MédicasRESUMEN
The Brazilian Stroke Society constituted a committee composed by specialists from different areas of Brazil that emitted a viewpoint called [quot ]National Opinion[quot ], written similar to the consensus pattern. The study purpose is to guide and offer subsidies for diagnosis and therapeutical plans for different situations in cerebrovascular diseases. The current article analyses [quot ]neuroprotective agents in stroke[quot ], discussing the level of evidence for the use of potential neuroprotective drugs and ongoing clinical trials.
Com finalidade de orientar e oferecer subsídios para a conduta diagnóstica e terapêutica em diferentes situações dentro das doenças cerebrovasculares, a Sociedade Brasileira de Doenças Cerebrovasculares (SBDCV) constituiu um comitê composto por neurologistas de diferentes áreas do Brasil que emitiram um parecer, denominado "Opinião Nacional", redigido nos moldes dos consensos. O presente artigo analisa a "neuroproteção no acidente vascular cerebral" discutindo o nível de evidência para o uso de drogas de potencial ação neuroprotetora e ensaios clínicos em andamento.